Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study

Journal of Hypertension

Volumn 19, Issue 6, 2001, Pages 1149-1159

  Zanchetti, Alberto ^a   Hansson, Lennart ^b   Dahlöf, Björn ^c   Elmfeldt, Dag ^d   Kjeldsen, Sverre ^e   Kolloch, Rainer ^f   Larochelle, Pierre ^g   McInnes, Gordon T ^h   Mallion, Jean Michel ⁱ   Ruilope, Luis ^j   Wedel, Hans ^k  

^a UNIVERSITY OF MILAN   (Italy)

^b UPPSALA UNIVERSITY   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^h UNIVERSITY OF GLASGOW   (United Kingdom)

ⁱ UNIV GRENOBLE ALPES   (France)

^j HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^k NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

more..

Author keywords

Age; Antihypertensive treatment; Cardiovascular risk factors; Diabetes; Gender; HOT Study; Hypercreatininaemia; Ischaemic heart disease; Smoking

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; CREATININE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GENDER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING;

EID: 0035010067     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200106000-00021     Document Type: Article

References (17)

1. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
2. Risk assessment and treatment benefit in the intensively treated hypertensive patients of the Hypertension Optimal Treatment (HOT) Study
3. 1999 World Health Organization•International Society of Hypertension guidelines for the management of hypertension
4. Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT Study
5. Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race-sex and age
6. Five-year findings of the Hypertension Detection and Follow-up Program. II. Reduction in stroke incidence among persons with high blood pressure
7. The effect of treatment on mortality in 'mild' hypertension. Results of the Hypertension Detection and Follow-up Program
8. Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. Five-year findings of the Hypertension Detection and Follow-up Program
9. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Result from the Hypertension Detection and Follow-up Program
10. Morbidity and mortality in patients randomized to doubleblind treatment with a long-acting calcium-channel blocker or diuretic in the Interventional Nifedipine GITS study: Intervention as a goal in hypertension treatment (INSIGHT)
11. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment
12. Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study
13. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
14. Diabetes mellitus and raised serum triglyceride concentration in treated hypertension - Are they of prognostic importance? Observational study
15. Identification of risk factors in hypertensive patients. Contribution of randomized controlled trials through an individual patient database
16. Stroke and coronary heart disease in mild hypertension: Risk factors and the value of treatment
17. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension